A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?

Arthritis Rheum. 1989 Jul;32(7):817-25.

Authors

E C Leroy¹, E A Smith, M B Kahaleh, M Trojanowska, R M Silver

Affiliation

¹ Department of Medicine, Medical University of South Carolina, Charleston.

PMID: 2665755

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Humans
Platelet-Derived Growth Factor / metabolism
Platelet-Derived Growth Factor / physiology
Scleroderma, Systemic / etiology*
Scleroderma, Systemic / metabolism
Scleroderma, Systemic / physiopathology
Transforming Growth Factors / physiology*
Tumor Necrosis Factor-alpha / metabolism
Tumor Necrosis Factor-alpha / physiology

Substances

Platelet-Derived Growth Factor
Tumor Necrosis Factor-alpha
Transforming Growth Factors